Last reviewed · How we verify
Treatment of neuropathic pain associated with diabetic peripheral neuropathy in adults — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Bat | bat | Pfizer | Unknown | Unknown |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in Treatment of neuropathic pain associated with diabetic peripheral neuropathy in adults
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Treatment of neuropathic pain associated with diabetic peripheral neuropathy in adults:
- Treatment of neuropathic pain associated with diabetic peripheral neuropathy in adults treatment updates — RSS
- Treatment of neuropathic pain associated with diabetic peripheral neuropathy in adults treatment updates — Atom
- Treatment of neuropathic pain associated with diabetic peripheral neuropathy in adults treatment updates — JSON
Cite this brief
Drug Landscape (2026). Treatment of neuropathic pain associated with diabetic peripheral neuropathy in adults — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/treatment-of-neuropathic-pain-associated-with-diabetic-peripheral-neuropathy-in-adults. Accessed 2026-06-10.
Related
- Treatment of neuropathic pain associated with diabetic peripheral neuropathy in adults full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing